These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The H7N9 influenza A virus infection results in lethal inflammation in the mammalian host via the NLRP3-caspase-1 inflammasome. Ren R; Wu S; Cai J; Yang Y; Ren X; Feng Y; Chen L; Qin B; Xu C; Yang H; Song Z; Tian D; Hu Y; Zhou X; Meng G Sci Rep; 2017 Aug; 7(1):7625. PubMed ID: 28790324 [TBL] [Abstract][Full Text] [Related]
9. Impaired NLRP3 inflammasome expression and function in atopic dermatitis due to Th2 milieu. Niebuhr M; Baumert K; Heratizadeh A; Satzger I; Werfel T Allergy; 2014 Aug; 69(8):1058-67. PubMed ID: 24894535 [TBL] [Abstract][Full Text] [Related]
10. IMQ-induced skin inflammation in mice is dependent on IL-1R1 and MyD88 signaling but independent of the NLRP3 inflammasome. Rabeony H; Pohin M; Vasseur P; Petit-Paris I; Jégou JF; Favot L; Frouin E; Boutet MA; Blanchard F; Togbe D; Ryffel B; Bernard FX; Lecron JC; Morel F Eur J Immunol; 2015 Oct; 45(10):2847-57. PubMed ID: 26147228 [TBL] [Abstract][Full Text] [Related]
12. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263 [TBL] [Abstract][Full Text] [Related]
13. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Baroja-Mazo A; Martín-Sánchez F; Gomez AI; Martínez CM; Amores-Iniesta J; Compan V; Barberà-Cremades M; Yagüe J; Ruiz-Ortiz E; Antón J; Buján S; Couillin I; Brough D; Arostegui JI; Pelegrín P Nat Immunol; 2014 Aug; 15(8):738-48. PubMed ID: 24952504 [TBL] [Abstract][Full Text] [Related]
14. Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production. Hu Y; Mao K; Zeng Y; Chen S; Tao Z; Yang C; Sun S; Wu X; Meng G; Sun B J Immunol; 2010 Dec; 185(12):7699-705. PubMed ID: 21048113 [TBL] [Abstract][Full Text] [Related]
15. Cutting edge: SHARPIN is required for optimal NLRP3 inflammasome activation. Gurung P; Lamkanfi M; Kanneganti TD J Immunol; 2015 Mar; 194(5):2064-7. PubMed ID: 25637014 [TBL] [Abstract][Full Text] [Related]
17. Chronic proliferative dermatitis in Sharpin null mice: development of an autoinflammatory disease in the absence of B and T lymphocytes and IL4/IL13 signaling. Potter CS; Wang Z; Silva KA; Kennedy VE; Stearns TM; Burzenski L; Shultz LD; Hogenesch H; Sundberg JP PLoS One; 2014; 9(1):e85666. PubMed ID: 24465642 [TBL] [Abstract][Full Text] [Related]
18. Caspase-4 is required for activation of inflammasomes. Sollberger G; Strittmatter GE; Kistowska M; French LE; Beer HD J Immunol; 2012 Feb; 188(4):1992-2000. PubMed ID: 22246630 [TBL] [Abstract][Full Text] [Related]
19. IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway. Cho KA; Suh JW; Lee KH; Kang JL; Woo SY Int Immunol; 2012 Mar; 24(3):147-58. PubMed ID: 22207130 [TBL] [Abstract][Full Text] [Related]
20. Cross-regulation between LUBAC and caspase-1 modulates cell death and inflammation. Douglas T; Saleh M J Biol Chem; 2020 Apr; 295(16):5216-5228. PubMed ID: 32122970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]